LAMTOR5 and breast cancer: In addition, we validated the expression levels of miR-183, miR-96 and miR-182 by qRT-PCR analysis (Wilcoxon signed-rank test, Supplementary Figure 2C), and HBXIP expression by IHC analysis in clinical breast cancer tissues (Supplementary Figure 2D).